- Home
- PHGE vs SISI Comparison
PHGE vs SISI Comparison
Compare PHGE & SISI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHGE
- SISI
- Stock Information
- Founded
- PHGE 2015
- SISI 1997
- Country
- PHGE Israel
- SISI China
- Employees
- PHGE N/A
- SISI N/A
- Industry
- PHGE Biotechnology: Pharmaceutical Preparations
- SISI Medicinal Chemicals and Botanical Products
- Sector
- PHGE Health Care
- SISI Health Care
- Exchange
- PHGE Nasdaq
- SISI Nasdaq
- Market Cap
- PHGE 13.3M
- SISI 14.9M
- IPO Year
- PHGE N/A
- SISI 2016
- Fundamental
- Price
- PHGE $0.61
- SISI $0.66
- Analyst Decision
- PHGE Strong Buy
- SISI
- Analyst Count
- PHGE 2
- SISI 0
- Target Price
- PHGE $23.00
- SISI N/A
- AVG Volume (30 Days)
- PHGE 191.3K
- SISI 567.3K
- Earning Date
- PHGE 05-19-2025
- SISI 05-14-2025
- Dividend Yield
- PHGE N/A
- SISI N/A
- EPS Growth
- PHGE N/A
- SISI N/A
- EPS
- PHGE N/A
- SISI N/A
- Revenue
- PHGE N/A
- SISI $11,072,553.00
- Revenue This Year
- PHGE N/A
- SISI N/A
- Revenue Next Year
- PHGE N/A
- SISI N/A
- P/E Ratio
- PHGE N/A
- SISI N/A
- Revenue Growth
- PHGE N/A
- SISI 145.88
- 52 Week Low
- PHGE $0.48
- SISI $0.39
- 52 Week High
- PHGE $4.99
- SISI $117.65
- Technical
- Relative Strength Index (RSI)
- PHGE 54.10
- SISI 42.87
- Support Level
- PHGE $0.52
- SISI $0.39
- Resistance Level
- PHGE $0.57
- SISI $0.94
- Average True Range (ATR)
- PHGE 0.05
- SISI 0.19
- MACD
- PHGE 0.01
- SISI -0.01
- Stochastic Oscillator
- PHGE 80.46
- SISI 38.12
About PHGE BiomX Inc. COmmon Stock
BiomX Inc is a clinical-stage microbiome company based in Israel. The company is engaged in developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria that affect the appearance of the skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease, colorectal cancer, and primary sclerosing cholangitis. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF.
About SISI Shineco Inc.
Shineco Inc aims to care for a healthy life and improve the quality of life by providing safe, efficient, and high-quality health products and services to society. The company has researched and developed various vitro diagnostic reagents and related medical devices to date, and it also produces and sells healthy and nutritious food.